title: Hormonal substitution during menopause: what are we treating?
abstract: OBJECTIVE
  It is suggested that during menopausal transition, women with vasomotor symptoms benefit from HRT, (hormone replacement therapy) whereas, the use of HRT for other cognitive-vegetative symptoms is questionable.
  
  
  METHODS
  The occurrence of menopausal complaints and depressive symptoms was assessed cross-sectionally in 5896 Dutch Caucasian women (47-54 years) of a large community sample in the city of Eindhoven, The Netherlands. Menopausal complaints were assessed using a 22 items self-rating scale (consisting of a vasomotor, uro-genital and a cognitive-vegetative subscale). Depressive symptoms were assessed using the Edinburgh depression scale (EDS). Differences in mean scores were analysed between groups using ANOVA. The independent relationship of depressive symptoms to the intensity of menopausal complaints was assessed, by multiple linear regression analysis.
  
  
  RESULTS
  Women using HRT showed the highest scores on all subscales. Oral contraceptive users had significantly lower scores on the vasomotor subscale compared to HRT users and to non users. Depressive symptoms contributed the most, to the explained variance on scores on the menopausal subscales.
  
  
  CONCLUSIONS
  Women during menopause presenting several complaints, other than vasomotor origin might be suffering from underlying depression which makes it questionable to prescribe HRT for the latter symptoms.
authors.affiliation: Diagnostic Centre Eindhoven, The Netherlands.
authors.forename: L W
authors.initials: LW
authors.lastname: Maartens
authors.forename: G L
authors.initials: GL
authors.lastname: Leusink
authors.forename: J A
authors.initials: JA
authors.lastname: Knottnerus
authors.forename: V J
authors.initials: VJ
authors.lastname: Pop
mesh_terms: D000339:Affect / Q000187:drug effects; D000704:Analysis of Variance; D003071:Cognition / Q000187:drug effects; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003863:Depression / Q000517:prevention & control; D005221:Fatigue / Q000517:prevention & control; D005260:Female; D005483:Flushing / Q000517:prevention & control; D020249:Hormone Replacement Therapy; D006801:Humans; D016014:Linear Models; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D011596:Psychomotor Disorders / Q000517:prevention & control; D012893:Sleep Wake Disorders / Q000517:prevention & control; D013546:Sweating / Q000187:drug effects; D014555:Urination Disorders / Q000517:prevention & control; D014623:Vaginal Diseases / Q000517:prevention & control; D014666:Vasomotor System / Q000187:drug effects
chemical_list: D003278:Contraceptives, Oral, Hormonal